We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Executive summary of quality assurance (QA) visit to East and North Hertfordshire bowel cancer screening programme on 29 January 2019.
Executive summary of quality assurance (QA) visit to Gateshead Health NHS Foundation Trust held on 22 May 2018.
Executive summary of quality assurance (QA) visit to Gloucestershire and Swindon held on 3 April 2019.
Executive summary of quality assurance (QA) visit to Hampshire bowel cancer screening programme held on 13 December 2017.
Executive summary of quality assurance (QA) visit to Harrogate and District Foundation Trust, held on 7 February 2018.
Executive summary of quality assurance (QA) visit to Health Services Laboratories on 5 and 12 June 2017.
Executive summary of quality assurance (QA) visit to Isle of Wight NHS Trust held on 19 June 2018.
Newborn blood spot child health records department (CHRD) annual standards return 2024 to 2025
Guidance for laboratories on reporting newborn blood spot screen positive results to Child Health Information Service and Newborn Blood Spot Failsafe Solution
Report of data reported against screening standards for the NHS newborn hearing screening programme.
Guidance on the use of mydriatic eye drops in the NHS diabetic eye screening (DES) programme.
This specification defines requirements for generating standard sticky labels with newborns' NHS numbers, to complete the newborn blood spot screening card.
Information about activities carried out by the 6 individual Research Advisory Committees (RACs) for all 11 NHS national population screening programmes.
Terms of reference for NHS population screening programme research advisory committees.
This guidance explains how local programmes, providers and commissioners can share learning about NHS population screening programmes.
Guidance and resources for carers and care providers to help people understand and access screening.
Executive summary of quality assurance (QA) visit to North Nottingham held on 25 April 2018.
Information for parents to explain what it means to have a positive screening result for carrying the cystic fibrosis (CF) gene.
Sickle cell and thalassaemia high/low prevalence laboratory return 2024 to 2025
Executive summary of quality assurance (QA) visit to Taunton and Somerset NHS Foundation Trust antenatal and newborn screening programmes on 17 September 2019.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).